Skip to content
drillr
.ai
Product
▼
Datasets
▼
Docs
(opens in a new tab)
Pricing
Research
Benchmark
Sign in
Sign up
L
LIMN
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ
Healthcare
Biotechnology
US
NASDAQ · Healthcare · Biotechnology · US
$3.71
+0.27%
+ Watch
Ask drillr
Overview
Financials
Valuation
Profitability
Growth
Capital
Momentum
Earnings
Ownership
News
Analysis
Analysis
No published Drillr research on LIMN yet.
Ask Drillr about LIMN
Browse research →
